Thursday March 05th, 2009

IDIBAPS Receives Accreditation as a Health Care Research Institute from the Ministry of Science and Innovation

L'IDIBAPS, acreditat pel IIS

Accreditations for Health Care Research Institutes were awarded for the first time at an event held today at the Carlos III Health Institute in Madrid. The Institute d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) – Hospital Clínic, Barcelona was the first center to be accredited and this fact has now been formalized. A further 3 Catalan centers have now joined IDIBAPS – the research institutes of the Vall d’Hebron, Bellvitge and Germans Trias i Pujol hospitals. Apart from the 4 Catalan hospitals, the Biomedicine Institute of Seville (IBIS) has also been accredited.

Read the rest of this entry »

No Comments
Wednesday March 04th, 2009

The Minister for Health and the Mayor of Barcelona Commit to Seeking Solutions to Expand the Les Corts Primary Care Center

El grup d'autoritats durant la seva visita al CAP Les Corts

As part of the visits of the Minister for Health to the different districts of the city, authorities from Barcelona City Council, the Ministry, the Provincial Government of Barcelona and the Councillor for the Les Corts district visited the Les Corts Primary Care Center yesterday, Monday, with the aim of evaluating the possibility of expanding the center’s facilities by 500 m2 in order to improve the quality of care to the people of the district.

Read the rest of this entry »

No Comments
Friday February 27th, 2009

Principal Cause of Cerebral Atrophy in Multiple Sclerosis Unknown.

Dr. Pablo Villoslada

Until now, it was thought that the lesions or plaques observed in the white matter were the cause of the damage to the brain. New data indicates that these plaques account for only 30% of the atrophy in the grey matter; other unexplained neurodegenerative mechanisms are therefore also implicated. Read the rest of this entry »

No Comments
Tuesday February 24th, 2009

A New Technology Identifies Genes Implicated in the Development of Liver Cancer.

Dr. Augusto Villanueva i Dr. Josep Mª Llovet

This study, published in the journal Nature Biotechnology and led by Dr. Josep Maria Llovet of Hospital Clínic de  Barcelona – IDIBAPS together with researchers from the University of Minnesota (USA), describes for the first time a new technology for genetic manipulation in experimental animals for identifying therapeutic targets that facilitate the development of drugs that improve patient outcome.

Read the rest of this entry »

No Comments
Friday February 20th, 2009

Stem Cells to Treat Crohn’s Disease

When drugs don’t work and surgery is not possible, transplanting stem cells from the patient’s own bone marrow is an effective alternative for the treatment of this chronic disease.

Equip mèdic de l'Hospital Clínic amb els tres pacients intervinguts

Cellular therapy with stem cells is revolutionizing the focus of treatment of many serious diseases. Replacing the cells of damaged tissue with other new cells from the same patient is already a reality. This is the basis of cellular therapy and regenerative medicine, the latest great advance in biomedicine. In this line, Hospital Clínic, Barcelona is leading the world in the application of an innovative cellular therapy that uses stem cells to treat Crohn’s disease, a chronic genetic disease that affects 1% of the population in Spain and which has considerable impact on the quality of life of the patients. The procedure is based on an autologous bone-marrow transplant (when patients receive a transplant of their own stem cells) and now constitutes a treatment option to cure an intestinal disease that sometimes does not successfully respond to drugs and requires highly complex surgery that does not provide a cure.

Read the rest of this entry »

No Comments

Categories

Posted in:

Chagas Disease: a Disease Without Frontiers

Vídeo Clínic-UB sobre què és la Malaltia de Chagas i per què és un problema global. Read the rest of this entry »

No Comments
Page 101 of 103« First...99100101102103